ORCHPHARMAPharmaceuticals
Orchid Pharma Ltd — Balance Sheet
₹482.45
-5.52%
Orchid Pharma Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Invested Capital | 1.44K Cr | 1.30K Cr | 1.02K Cr | 915.33 Cr | — |
| Working Capital | 521.85 Cr | 530.78 Cr | 129.12 Cr | 156.87 Cr | — |
| Net Tangible Assets | 1.25K Cr | 1.15K Cr | 688.26 Cr | 647.04 Cr | — |
| Capital Lease Obligations | 0.37 Cr | 0.70 Cr | 0.00 | — | — |
| Common Stock Equity | 1.27K Cr | 1.17K Cr | 688.65 Cr | 647.38 Cr | — |
| Total Capitalization | 1.40K Cr | 1.29K Cr | 837.49 Cr | 855.55 Cr | — |
| Total Equity Gross Minority Interest | 1.27K Cr | 1.17K Cr | 688.65 Cr | 647.38 Cr | — |
| Stockholders Equity | 1.27K Cr | 1.17K Cr | 688.65 Cr | 647.38 Cr | — |
| Other Equity Interest | 1.22K Cr | 68.56 Cr | 68.56 Cr | 68.56 Cr | — |
| Capital Stock | 50.72 Cr | 50.72 Cr | 40.82 Cr | 40.82 Cr | — |
| Common Stock | 50.72 Cr | 50.72 Cr | 40.82 Cr | 40.82 Cr | — |
| Total Liabilities Net Minority Interest | 420.63 Cr | 384.41 Cr | 536.56 Cr | 463.18 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 135.06 Cr | 124.43 Cr | 164.67 Cr | 222.40 Cr | — |
| Long Term Debt And Capital Lease Obligation | 131.67 Cr | 120.80 Cr | 148.84 Cr | 208.17 Cr | — |
| Long Term Capital Lease Obligation | 0.04 Cr | 0.37 Cr | 0.00 | — | — |
| Long Term Debt | 131.64 Cr | 120.43 Cr | 148.84 Cr | 208.17 Cr | — |
| Long Term Provisions | 3.39 Cr | 3.63 Cr | 12.60 Cr | — | 11.54 Cr |
| Current Liabilities | 285.57 Cr | 259.97 Cr | 371.89 Cr | 240.78 Cr | — |
| Other Current Liabilities | 18.17 Cr | 3.59 Cr | 1.48 Cr | 0.98 Cr | — |
| Current Debt And Capital Lease Obligation | 42.94 Cr | 14.38 Cr | 182.51 Cr | 59.79 Cr | — |
| Current Capital Lease Obligation | 0.33 Cr | 0.33 Cr | 0.00 | — | — |
| Current Debt | 42.60 Cr | 14.05 Cr | 182.51 Cr | 59.79 Cr | — |
| Current Provisions | 2.37 Cr | 2.08 Cr | 3.49 Cr | — | 3.52 Cr |
| Payables | 222.09 Cr | 237.97 Cr | 182.74 Cr | 168.21 Cr | — |
| Accounts Payable | 222.09 Cr | 229.58 Cr | 174.37 Cr | 167.68 Cr | — |
| Total Assets | 1.69K Cr | 1.55K Cr | 1.23K Cr | 1.11K Cr | — |
| Total Non Current Assets | 880.50 Cr | 763.12 Cr | 724.20 Cr | 712.91 Cr | — |
| Other Non Current Assets | 61.83 Cr | 9.13 Cr | 2.02 Cr | — | 5.12 Cr |
| Investmentin Financial Assets | 53.94 Cr | 45.84 Cr | 44.44 Cr | 45.50 Cr | — |
| Available For Sale Securities | 53.94 Cr | 45.84 Cr | 44.44 Cr | 45.50 Cr | — |
| Goodwill And Other Intangible Assets | 17.01 Cr | 14.92 Cr | 0.39 Cr | 0.34 Cr | — |
| Other Intangible Assets | 17.01 Cr | 14.92 Cr | 0.39 Cr | 0.34 Cr | — |
| Net PPE | 696.41 Cr | 645.12 Cr | 621.19 Cr | 604.82 Cr | — |
| Gross PPE | 696.41 Cr | 1.31K Cr | 1.26K Cr | 1.19K Cr | — |
| Construction In Progress | 64.49 Cr | 25.52 Cr | 48.48 Cr | 21.45 Cr | — |
| Other Properties | 631.92 Cr | 16.32 Cr | 16.32 Cr | 16.32 Cr | — |
| Current Assets | 807.42 Cr | 790.75 Cr | 501.01 Cr | 397.65 Cr | — |
| Other Current Assets | 53.76 Cr | 58.26 Cr | 25.34 Cr | 5.89 Cr | — |
| Current Deferred Taxes Assets | 0.10 Cr | — | — | — | — |
| Inventory | 326.37 Cr | 264.23 Cr | 228.74 Cr | 172.66 Cr | — |
| Taxes Receivable | 2.67 Cr | 1.64 Cr | 0.95 Cr | 0.32 Cr | — |
| Accounts Receivable | 241.83 Cr | 195.55 Cr | 215.19 Cr | 170.57 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 182.68 Cr | 4.52 Cr | 27.52 Cr | 4.83 Cr | — |
| Other Short Term Investments | 161.57 Cr | 0.92 Cr | 4.92 Cr | 0.52 Cr | — |
| Cash And Cash Equivalents | 21.11 Cr | 3.60 Cr | 22.60 Cr | 4.31 Cr | — |
| Ordinary Shares Number | 5.07 Cr | 5.07 Cr | 4.08 Cr | 4.08 Cr | — |
| Share Issued | 5.07 Cr | 5.07 Cr | 4.08 Cr | 4.08 Cr | — |
| Net Debt | 153.13 Cr | 130.88 Cr | 308.75 Cr | 263.65 Cr | — |
| Total Debt | 174.61 Cr | 135.18 Cr | 331.35 Cr | 267.95 Cr | — |
| Tangible Book Value | 1.25K Cr | 1.15K Cr | 688.26 Cr | 647.04 Cr | — |
| Retained Earnings | — | -2.18K Cr | -2.27K Cr | -2.31K Cr | -2.31K Cr |
| Additional Paid In Capital | — | 846.52 Cr | 464.48 Cr | 464.48 Cr | 464.48 Cr |
| Non Current Pension And Other Postretirement Benefit Plans | — | 3.63 Cr | 12.60 Cr | 11.01 Cr | 11.54 Cr |
| Non Current Deferred Taxes Liabilities | — | 0.00 | 3.23 Cr | 3.23 Cr | 3.23 Cr |
| Pensionand Other Post Retirement Benefit Plans Current | — | 2.08 Cr | 3.49 Cr | 3.01 Cr | 3.52 Cr |
| Other Payable | — | 8.39 Cr | 8.37 Cr | 0.53 Cr | 2.53 Cr |
| Non Current Prepaid Assets | — | 5.95 Cr | 6.87 Cr | 10.02 Cr | 9.10 Cr |
| Accumulated Depreciation | — | -669.20 Cr | -637.09 Cr | -582.35 Cr | -495.36 Cr |
| Machinery Furniture Equipment | — | 1.06K Cr | 993.38 Cr | 993.17 Cr | 992.89 Cr |
| Buildings And Improvements | — | 185.88 Cr | 178.26 Cr | 143.94 Cr | 143.94 Cr |
| Land And Improvements | — | 25.65 Cr | 21.85 Cr | 12.29 Cr | 12.29 Cr |
| Properties | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Assets Held For Sale Current | — | 0.00 | 0.00 | 13.29 Cr | 120.85 Cr |
| Restricted Cash | — | 262.04 Cr | 3.11 Cr | 3.24 Cr | 3.42 Cr |
| Prepaid Assets | — | 57.96 Cr | 25.34 Cr | 26.87 Cr | 98.43 Cr |
| Other Inventories | — | 2.90 Cr | 3.99 Cr | 2.36 Cr | 3.47 Cr |
| Finished Goods | — | 74.42 Cr | 67.95 Cr | 54.84 Cr | 53.81 Cr |
| Work In Process | — | 114.87 Cr | 77.45 Cr | 69.08 Cr | 55.56 Cr |
| Raw Materials | — | 72.04 Cr | 79.35 Cr | 46.37 Cr | 40.04 Cr |
| Other Receivables | — | 4.81 Cr | 0.16 Cr | 14000.00 | 0.07 Cr |
| Allowance For Doubtful Accounts Receivable | — | -43.48 Cr | -43.74 Cr | -42.56 Cr | -67.22 Cr |
| Gross Accounts Receivable | — | 239.03 Cr | 258.94 Cr | 213.12 Cr | 202.92 Cr |
| Cash Equivalents | — | 0.00 | 0.00 | 0.00 | 11.70 Cr |
| Cash Financial | — | 3.60 Cr | 22.60 Cr | 4.31 Cr | 3.99 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Orchid Pharma Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.